MK021
A 24-Week, Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Assess Anacetrapib When Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low HDL-C
- Stadium
- klaar
- Middel
- Anacetrapib
- Populatie
- Diabetes Mellitus
- Fase
- III
- First Patient In
- 1 januari 2012
- Last Patient In
- -
- Last Patient Last Visit
- -
Contact Bestuur
